Ozempic Lawsuit 2026: Stomach Injuries, Vision Loss & Legal Rights
Ozempic lawsuits continue to develop in 2026 as patients allege that certain GLP-1 medications caused serious gastrointestinal injuries and, in separate litigation, vision-related injuries.
Ozempic contains semaglutide and is manufactured by Novo Nordisk. The FDA-approved prescribing information states that Ozempic can cause gastrointestinal adverse reactions, including severe reactions, and says the medication is not recommended for patients with severe gastroparesis.
At the same time, federal courts are handling product-liability cases involving alleged injuries associated with GLP-1 receptor agonists. Two major federal multidistrict litigations (MDLs) are currently relevant: MDL 3094, involving alleged gastrointestinal injuries, and MDL 3163, involving alleged non-arteritic anterior ischemic optic neuropathy (NAION).
If you or a family member experienced a serious medical condition after using Ozempic or another GLP-1 medication, the circumstances of your case, medical records, diagnosis, medication history, and state filing deadline may determine whether you have a potential legal claim.
Important: This article provides general information, not legal or medical advice. A lawsuit does not establish that a medication caused an injury in every individual case. Speak with a qualified healthcare professional about medical concerns and a licensed attorney about your legal rights.
What Is Ozempic and Why Are Lawsuits Being Filed?
Ozempic is a prescription medication containing semaglutide, a GLP-1 receptor agonist. It is approved for specific uses related to type 2 diabetes and works partly by slowing gastric emptying and affecting appetite and blood glucose regulation.
The FDA’s current prescribing information warns that Ozempic may cause gastrointestinal adverse reactions, sometimes severe, and states that it is not recommended for people with severe gastroparesis.
Product-liability lawsuits are different from FDA approval or regulatory action. In litigation, plaintiffs may allege that a manufacturer failed to adequately warn about certain risks or that the product presented other legal problems.
The defendants have disputed allegations made in the litigation.
What Are the Main Allegations in Ozempic Litigation?
One important legal theory in the GLP-1 litigation is failure to warn.
A plaintiff may argue that a manufacturer had information about a potential risk and failed to provide adequate warnings to doctors or patients. Other claims can include design-defect or warranty-related allegations, depending on the particular lawsuit and jurisdiction.
However, the existence of an MDL does not mean that every allegation has been proven. Courts use the litigation process to address disputed factual and legal questions.
Common Legal Theories
| Legal Theory | General Meaning |
|---|---|
| Failure to Warn | Allegation that warnings about a risk were inadequate |
| Design Defect | Allegation that a product was unreasonably dangerous because of its design |
| Breach of Warranty | Allegation involving representations or warranties about the product |
| Misrepresentation | Allegation that information about a product was false or misleading |
The specific claims available to a plaintiff depend on the facts of the case and applicable state law.
Health Conditions Mentioned in Ozempic Lawsuits
The litigation includes different alleged injuries. The two major federal MDLs currently focus on different categories.
1. Gastroparesis
Gastroparesis is a condition involving delayed movement of food from the stomach into the small intestine.
Symptoms can include:
- Nausea or vomiting
- Abdominal pain
- Bloating
- Feeling full quickly
- Difficulty tolerating food
- Delayed stomach emptying
The FDA prescribing information states that Ozempic is not recommended for patients with severe gastroparesis and warns about severe gastrointestinal adverse reactions.
A medical diagnosis is important because ordinary temporary digestive symptoms do not automatically establish gastroparesis or create a legal claim.
2. Ileus and Bowel-Related Injuries
Ileus involves reduced or absent movement of the intestines. Some product-liability cases involving GLP-1 medications allege serious bowel-related injuries.
Whether a particular patient experienced an ileus, obstruction, or another gastrointestinal condition must be determined through medical evaluation and records.
3. NAION and Vision Loss
A separate federal MDL concerns allegations involving non-arteritic anterior ischemic optic neuropathy (NAION).
NAION is an optic-nerve condition that can result in sudden vision changes or vision loss. The MDL concerns allegations that certain GLP-1 receptor agonists were associated with NAION.
The federal court’s description of MDL 3163 identifies Ozempic, Wegovy, Saxenda, and Trulicity among the medications involved in the litigation and states that plaintiffs allege NAION injuries.
Importantly, the litigation itself is not proof that every person taking these medications will develop NAION.
Current Ozempic Lawsuit Status in 2026
As of August 2026, federal litigation involving GLP-1 medications remains active.
MDL 3094: Gastrointestinal Injuries
MDL 3094 is pending in the U.S. District Court for the Eastern District of Pennsylvania and concerns alleged gastrointestinal injuries associated with GLP-1 receptor agonists.
The court explains that the litigation involves common factual questions concerning issues such as whether defendants knew or should have known about alleged gastrointestinal risks and whether warnings and representations were adequate.
The defendants deny the allegations.
MDL 3163: NAION Vision-Loss Claims
MDL 3163 is a separate federal proceeding concerning alleged NAION injuries.
The Judicial Panel on Multidistrict Litigation centralized these cases in the Eastern District of Pennsylvania because they involve common factual questions concerning the development, testing, regulatory history, promotion, labeling, and alleged capacity of the medications to cause NAION.
The court has issued multiple case-management orders during 2026, including orders addressing science presentations, discovery, and other pretrial procedures.
Has Ozempic Reached a Nationwide Settlement?
You should not assume that a settlement amount exists simply because lawsuits have been consolidated into an MDL.
An MDL is primarily a mechanism for coordinating federal cases and conducting pretrial proceedings efficiently. It does not automatically mean that plaintiffs will receive a particular payment.
Settlement discussions, if any, can change over time, so readers should rely on current court records and qualified legal counsel rather than advertisements promising a specific payout.
Who May Qualify for an Ozempic Lawsuit?
There is no single checklist that guarantees eligibility.
A lawyer evaluating a potential case may consider factors such as:
Medication History
You may need documentation showing which medication you used, when you used it, the prescribed dose, and how long you took it.
Diagnosed Injury
A serious medical diagnosis is generally more significant than ordinary or temporary side effects.
Potentially relevant diagnoses may include:
- Gastroparesis
- Ileus
- Bowel obstruction
- Other serious gastrointestinal injuries
- NAION or qualifying vision loss
Medical Documentation
Medical records can help establish:
- The diagnosis
- When symptoms began
- Tests performed
- Treatment received
- Hospital or emergency-room visits
- Relevant medication history
Timing
The timing between medication use and the alleged injury can be important when evaluating causation.
Filing Deadline
Every state has its own statute of limitations rules. The deadline can depend on factors such as the type of claim, when the injury occurred, and when the injury was discovered.
Because missing a deadline can affect your legal rights, potential claimants should obtain state-specific legal advice rather than relying on a general time period found online.
What Medical Evidence May Be Important?
Medical documentation can play an important role in a product-liability case.
For gastrointestinal injuries, relevant records may include:
- Gastric emptying studies
- Endoscopy reports
- CT scans
- X-rays
- Hospital records
- Gastroenterology records
- Prescription history
For alleged NAION injuries, relevant records may include:
- Ophthalmology records
- Visual field testing
- Optical coherence tomography (OCT)
- Eye examination records
- Neurology records where applicable
The exact evidence required depends on the diagnosis and the legal theory involved.
How to Protect Your Rights After a Serious Injury
If you believe you experienced a serious medical problem after using Ozempic or another GLP-1 medication, consider taking the following general steps.
1. Seek Medical Attention
Your health should come first.
If you have serious or sudden symptoms, contact an appropriate healthcare professional or seek emergency care when necessary.
Do not change or stop a prescribed medication solely because of information in an online lawsuit article. Discuss medication decisions with your healthcare professional.
2. Request Your Medical Records
Keep copies of relevant:
- Doctor visits
- Hospital records
- Diagnostic tests
- Prescription records
- Medical bills
- Treatment notes
3. Keep Medication Information
If available, preserve prescription information, pharmacy records, packaging, and other documentation that may identify the medication and prescription details.
4. Write Down Important Dates
Create a simple timeline showing:
- When you started the medication
- Relevant dose changes
- When symptoms began
- Doctor visits
- Emergency-room visits
- Diagnosis dates
- Major treatments or procedures
5. Speak With a Qualified Attorney
A lawyer experienced in pharmaceutical or product-liability litigation can review the facts and explain whether you may have a potential claim.
Many personal-injury firms offer initial case evaluations, but fee arrangements vary. Always review the attorney’s fee agreement before proceeding.
How Much Could an Ozempic Lawsuit Be Worth?
There is no reliable universal settlement amount for an individual Ozempic lawsuit.
Potential damages can depend on the facts of the individual case, including:
- Medical expenses
- Future medical treatment
- Lost income
- Loss of earning capacity
- Physical pain
- Emotional distress
- Long-term disability
- The severity and duration of the injury
A serious diagnosis does not guarantee a particular settlement.
Likewise, online advertisements quoting a specific “average Ozempic settlement” should not be treated as a prediction of what an individual claim will be worth.
Gastroparesis vs. NAION Claims
| Category | Gastroparesis / GI Claims | NAION Claims |
|---|---|---|
| Main Injury | Delayed stomach emptying or other alleged GI injuries | Non-arteritic anterior ischemic optic neuropathy |
| Common Evidence | Gastric emptying study, medical records, imaging | Eye examination, visual field testing, OCT |
| Federal MDL | MDL 3094 | MDL 3163 |
| Main Legal Issues | Warning, causation, product-liability claims | Warning, causation, product-liability claims |
| Individual Result | Depends on facts and applicable law | Depends on facts and applicable law |
MDL vs. Class Action: What Is the Difference?
An MDL and a class action are not the same thing.
In multidistrict litigation, multiple individual cases involving common factual issues may be coordinated for pretrial proceedings.
A class action generally involves a defined class of people whose claims are handled under the requirements for class litigation.
Being included in an MDL does not necessarily mean that every plaintiff receives the same amount of compensation.
Common Mistakes to Avoid
Assuming Every Side Effect Creates a Lawsuit
A person experiencing a common or temporary side effect does not automatically have a product-liability claim.
Relying on Settlement Advertisements
Claims about guaranteed or specific payouts should be treated cautiously. No attorney can guarantee the outcome of an individual lawsuit.
Ignoring Medical Records
Medical documentation can be critical when evaluating causation and the extent of an alleged injury.
Waiting Until the Deadline Is Close
Statutes of limitations vary by state. Waiting too long can create serious legal problems.
Treating Online Information as Medical Advice
An article about litigation should not replace medical advice. Discuss symptoms and medication decisions with a qualified healthcare professional.
Frequently Asked Questions
Can I sue if I used Ozempic for weight loss?
Eligibility depends on the circumstances of your prescription, the injury you experienced, medical evidence, causation issues, and applicable law. A lawyer can evaluate the specific facts.
Does Ozempic cause gastroparesis?
Ozempic’s FDA prescribing information recognizes severe gastrointestinal adverse reactions and states that it is not recommended for people with severe gastroparesis. Whether Ozempic caused a particular person’s condition is an individual medical and legal question.
Is there an Ozempic vision-loss lawsuit?
Yes. MDL 3163 is a federal multidistrict litigation concerning alleged NAION injuries associated with certain GLP-1 receptor agonists, including Ozempic and other medications.
What is MDL 3094?
MDL 3094 is a federal multidistrict litigation involving alleged gastrointestinal injuries associated with GLP-1 receptor agonists.
What is MDL 3163?
MDL 3163 is a separate federal multidistrict litigation involving alleged NAION injuries associated with GLP-1 receptor agonists.
Is there a guaranteed Ozempic settlement?
No. A lawsuit or MDL does not guarantee compensation. The value and outcome of an individual claim depend on the evidence, applicable law, and litigation outcome.
What should I do if I think Ozempic injured me?
First, seek appropriate medical care. Keep your medical and prescription records, document important dates, and consider speaking with a qualified attorney about your potential legal rights.
Final Takeaway
Ozempic-related litigation remains active in 2026, with separate federal MDLs addressing alleged gastrointestinal injuries and NAION-related vision injuries.
The existence of these lawsuits does not mean that Ozempic has been proven to cause every alleged injury. Individual cases require evidence concerning medication use, diagnosis, medical history, causation, and applicable law.
If you believe you suffered a serious injury after using Ozempic or another GLP-1 medication, focus first on obtaining appropriate medical care and preserving your records. A qualified product-liability attorney can then review your circumstances and explain whether you may have a potential legal claim.
This article is for general informational purposes only and does not constitute legal or medical advice.